Pharmacogenetics-based new therapeutic concepts (Q35956177)

11 August 2017

1 reference

title

Pharmacogenetics-based new therapeutic concepts (English)

1 reference

11 August 2017

Ingolf Cascorbi

9

0 references

Julia C Stingl

object named as

Julia Kirchheiner

4

0 references

author name string

Ivar Roots

1

1 reference

11 August 2017

Thomas Gerloff

2

1 reference

11 August 2017

Christian Meisel

3

1 reference

11 August 2017

Mark Goldammer

5

1 reference

11 August 2017

Rolf Kaiser

6

1 reference

11 August 2017

Gabriele Laschinski

7

1 reference

11 August 2017

Jürgen Brockmöller

8

1 reference

11 August 2017

Ullrich Kleeberg

10

1 reference

11 August 2017

Alfred G Hildebrandt

11

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

11 August 2017

published in

Drug Metabolism Reviews

1 reference

11 August 2017

volume

36

1 reference

11 August 2017

issue

3-4

1 reference

11 August 2017

page(s)

617-638

1 reference

Role of transport proteins in drug absorption, distribution and excretion

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

PlA2 polymorphism and efficacy of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Investigation of the association between 5-HT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Effects of Polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on Trimipramine Pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

21 January 2018

Membrane transporters

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

[Activation of detoxication in liver microsome during addiction].

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Nonlinear kinetics after high-dose omeprazole caused by saturation of genetically variable CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

A common polymorphism associated with antibiotic-induced cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Role of P-glycoprotein in drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Dyspeptic symptoms associated with Helicobacter pylori infection are influenced by strain and host specific factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033458

21 January 2018

Identifiers

DOI

10.1081/DMR-200033458

1 reference

11 August 2017

1 reference